Harding Loevner’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45.7M Sell
116,130
-52,577
-31% -$21M 0.5% 40
2026
Q2
$65.2M Sell
168,707
-43,132
-20% -$16M 0.61% 44
2026
Q1
$62M Sell
211,839
-8,886
-4% -$2.92M 0.64% 51
2025
Q4
$77.4M Sell
220,725
-25,640
-10% -$8.66M 0.68% 46
2025
Q3
$79.6M Buy
+246,365
New +$76.6M 0.58% 49
2020
Q3
– Sell
-800
Closed -$210K – 182
2020
Q2
$210K Hold
800
– – ﹤0.01% 79
2020
Q1
$182K Hold
800
– – ﹤0.01% 86
2019
Q4
$242K Hold
800
– – ﹤0.01% 85
2019
Q3
$192K Hold
800
– – ﹤0.01% 78
2019
Q2
$226K Hold
800
– – ﹤0.01% 81
2019
Q1
$230K Hold
800
– – ﹤0.01% 76
2018
Q4
$210K Hold
800
– – ﹤0.01% 77
2018
Q3
$219K Hold
800
– – ﹤0.01% 75
2018
Q2
$190K Hold
800
– – ﹤0.01% 74
2018
Q1
$176K Hold
800
– – ﹤0.01% 77
2017
Q4
$180K Hold
800
– – ﹤0.01% 75
2017
Q3
$152K Hold
800
– – ﹤0.01% 77
2017
Q2
$151K Buy
+800
New +$144K ﹤0.01% 72
2016
Q4
– Sell
-800
Closed -$100K – 82
2016
Q3
$100K Hold
800
– – ﹤0.01% 75
2016
Q2
$105K Hold
800
– – ﹤0.01% 71
2016
Q1
$111K Hold
800
– – ﹤0.01% 72
2015
Q4
$112K Hold
800
– – ﹤0.01% 82
2015
Q3
$112K Hold
800
– – ﹤0.01% 79
2015
Q2
$131K Buy
+800
New +$128K ﹤0.01% 79
2015
Q1
– Sell
-800
Closed -$101K – 83
2014
Q4
$101K Hold
800
– – ﹤0.01% 84
2014
Q3
$96K Hold
800
– – ﹤0.01% 80
2014
Q2
$86K Hold
800
– – ﹤0.01% 79
2014
Q1
$80K Buy
+800
New +$72.4K ﹤0.01% 82
2013
Q4
– Sell
-800
Closed -$67K – 84
2013
Q3
$67K Hold
800
– – ﹤0.01% 83
2013
Q2
$65K Buy
+800
New +$59.9K ﹤0.01% 82

Other funds holding ELV

Harding Loevner's ELV Position: Q3 2026 in Review

Harding Loevner reduced its Elevance Health (ELV) stake by 31% in Q3 2026, selling an estimated $21M and leaving 116,130 shares worth $45.7M. The position accounts for 0.5% of the portfolio, ranked #40.

Harding Loevner first reported a position in ELV in Q2 2013 and has held it in 30 quarters since. The position peaked at $79.6M in Q3 2025. 1,604 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Harding Loevner held 116,130 shares of Elevance Health worth $45.7M as of Q3 2026.
  • Harding Loevner sold 52,577 Elevance Health shares in Q3 2026, an estimated $21M.
  • Elevance Health made up 0.5% of Harding Loevner's portfolio in Q3 2026, its #40 holding.
  • Harding Loevner first reported a position in Elevance Health in Q2 2013 and has held it in 30 quarters since.
  • Harding Loevner's Elevance Health position peaked at $79.6M in Q3 2025.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Harding Loevner's 13F filing for Q3 2026, filed 16 Nov 2026.